A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/16 (2006.01) A61K 31/4412 (2006.01) A61P 13/12 (2006.01) A61P 39/04 (2006.01)
Patent
CA 2576190
A human undergoing an injection of a contrast agent is treated by the administration of an iron chelator. Administration of the iron chelator can essentially prevent the onset of acute renal failure in a human. Administration of the iron chelator can reduce the severity of the acute renal failure and/or reduce the severity of kidney disease consequent to the acute renal failure.
Un humain recevant une injection d'un agent de contraste est traité par administration d'un chélateur de fer. L'administration du chélateur de fer peut pratiquement prévenir l'apparition d'une insuffisance rénale aiguë chez un humain. L'administration du chélateur de fer peut réduire la gravité de l'insuffisance rénale aiguë et/ou réduire la gravité de la maladie rénale consécutive à l'insuffisance rénale aiguë.
Gowling Lafleur Henderson Llp
Shiva Biomedical Llc
LandOfFree
Iron chelators for treating radiocontrast-associated renal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Iron chelators for treating radiocontrast-associated renal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iron chelators for treating radiocontrast-associated renal... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1924897